Redefining women's health with innovative solutions
Gameto is a biotechnology company redefining female reproductive health through cell engineering. Its lead product Fertilo uses iPSC-derived granulosa-like cells to improve IVF outcomes, having reached Phase 3 clinical trials. Founded in 2020 by Dina Radenkovic Turner and Martin Varsavsky, Gameto has raised over $117 million and secured a $10 million ARPA-H award.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2025
May 2024
Jan 2022
Mar 2020
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
